Barbosa, Amanda Veiga 
; Silva, Lucas Caetano Araujo ; Rotta, Inajara ; Aguiar, Patrícia Melo
Source: Heart, Lung and Circulation. Unidade: FCF
Subjects: INSUFICIÊNCIA CARDÍACA, MIOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Amanda Veiga et al. Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review. Heart, Lung and Circulation, v. 34, n. 11, p. 1169-1178, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.hlc.2025.04.082. Acesso em: 26 abr. 2026.APA
Barbosa, A. V., Silva, L. C. A., Rotta, I., & Aguiar, P. M. (2025). Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review. Heart, Lung and Circulation, 34( 11), 1169-1178. doi:10.1016/j.hlc.2025.04.082NLM
Barbosa AV, Silva LCA, Rotta I, Aguiar PM. Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review [Internet]. Heart, Lung and Circulation. 2025 ; 34( 11): 1169-1178.[citado 2026 abr. 26 ] Available from: https://dx.doi.org/10.1016/j.hlc.2025.04.082Vancouver
Barbosa AV, Silva LCA, Rotta I, Aguiar PM. Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review [Internet]. Heart, Lung and Circulation. 2025 ; 34( 11): 1169-1178.[citado 2026 abr. 26 ] Available from: https://dx.doi.org/10.1016/j.hlc.2025.04.082
